Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia. [electronic resource]
Producer: 19950117Description: 4368-73 p. digitalISSN:- 0006-4971
- Acute Disease
- Adult
- Bone Marrow Transplantation -- mortality
- Busulfan -- administration & dosage
- Cause of Death
- Child
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Female
- Graft vs Host Disease -- prevention & control
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Granulocyte-Macrophage Colony-Stimulating Factor -- therapeutic use
- Humans
- Immunologic Factors -- therapeutic use
- Infections -- etiology
- Interferons -- therapeutic use
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Leukemia, Myeloid, Accelerated Phase -- mortality
- Life Tables
- Male
- Middle Aged
- Multivariate Analysis
- Prognosis
- Recombinant Proteins -- therapeutic use
- Retrospective Studies
- Salvage Therapy
- Spleen -- pathology
- Splenectomy
- Survival Analysis
- Time Factors
- Treatment Outcome
- Washington -- epidemiology
- Whole-Body Irradiation -- adverse effects
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.; Review
There are no comments on this title.
Log in to your account to post a comment.